Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer
Titel:
Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer
Auteur:
Sanoff, Hanna K. Moon, Dominic H. Moore, Dominic T. Boles, Jeremiah Bui, Courtney Blackstock, William O'Neil, Bert H. Subramaniam, Somasundaram McRee, Autumn J. Carlson, Cheryl Lee, Michael S. Tepper, Joel E. Wang, Andrew Z.